Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wen-Xiao Yang
Observed names:
W T Yang,
Wen-xiao Yang
Institutions:
Fudan University Shanghai Cancer Center,
Shanghai University of Traditional Chinese Medicine,
Yueyang Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai University of Traditional Chinese Medicine,
Yueyang Hospital
ORCID:
0009-0007-0239-4671
Observed ORCID:
0009-0007-0239-4671
OpenAlex ID:
A5073046137
An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2023
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
·
Cancer Research
·
22
Targeting MORC2 activates transposable element-mediated viral mimicry and potentiates immune checkpoint blockade in triple-negative breast cancer
2026
·
Fang-Lin Zhang
, Shao-Ying Yang
, et al.
·
Molecular Cancer
·
2
[Advances and challenges in detection of HER2 low expression in breast cancer].
2022
·
Y P Liu
, W C Xue
, et al.
·
PubMed
·
2
The effectiveness of Traditional Chinese Medicine in treating cancer related anemia: a systematic review and meta-analysis
2026
·
Quan-yao Li
, Zi-yu Zhang
, et al.
·
Frontiers in Medicine
PDF
Table S1 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Table S4-6 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Figure S1-9 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S2 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S3 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S7 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S8 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Table S4-6 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S1 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Figure S1-9 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S7 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S2 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S3 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S8 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Data from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S3 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S7 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S1 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S8 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S2 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Table S4-6 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Show more works
View as search
Works count:
44
Citation count:
26
H-index:
2
I10-index:
1
Year
Topic
Type